Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyla N Price

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of the American Academy of Dermatology|April 1, 2020
COVID-19 and immunomodulator/immunosuppressant use in dermatologyKyla N Price, John W Frew, Jennifer L Hsiao, et al.
The Journal of Dermatological Treatment|April 21, 2020
Demystifying pharmaceutical patient assistance programsErin K Collier, Kyla N Price, Jennifer L Hsiao, et al.
Dermatology (Basel, Switzerland)|July 7, 2025
Ethnoracial and Geographic Disparities in Global Atopic Dermatitis Clinical Trials: An UpdateCaitlyn B Dagenet, Sahar Davoudi, Kyla N Price, et al.
The Journal of Dermatological Treatment|February 12, 2021
Medicaid and Medicare Part B spending on immunomodulators and biosimilarsAlyssa M Thompson, Swetha Atluri, Kyla N Price, et al.
The Journal of Investigative Dermatology|May 29, 2020
National Institutes of Health Dermatology Funding Trends 2015-2019Kyla N Price, Erin K Collier, Swetha Atluri, et al.
The Journal of Dermatological Treatment|October 18, 2019
A practical guide for transitioning from classical immunosuppressants to dupilumab in atopic dermatitisCatherine M Ludwig, Jeffrey M Krase, Kyla N Price, et al.
Dermatology Online Journal|December 20, 2020
Widespread pustular eruption following probiotic useKyla N Price, Aleksi J Hendricks, Mackenzie E Goodrich, et al.
Dermatology (Basel, Switzerland)|December 15, 2020
Facilitating Clinical Trials Participation of Low Socioeconomic Status PatientsKyla N Price, Alexis B Lyons, Iltefat H Hamzavi, et al.
Dermatology Online Journal|April 5, 2021
Hidradenitis suppurativa patient perspectives during the COVID-19 pandemicKyla N Price, Erin K Collier, Tristan R Grogan, et al.
Endocrine Connections|August 3, 2021
Diabetes control is associated with environmental quality in the USAJyotsna S Jagai, Alison K Krajewski, Kyla N Price, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of the American Academy of Dermatology|April 1, 2020
COVID-19 and immunomodulator/immunosuppressant use in dermatologyKyla N Price, John W Frew, Jennifer L Hsiao, et al.
The Journal of Dermatological Treatment|April 21, 2020
Demystifying pharmaceutical patient assistance programsErin K Collier, Kyla N Price, Jennifer L Hsiao, et al.
Dermatology (Basel, Switzerland)|July 7, 2025
Ethnoracial and Geographic Disparities in Global Atopic Dermatitis Clinical Trials: An UpdateCaitlyn B Dagenet, Sahar Davoudi, Kyla N Price, et al.
The Journal of Dermatological Treatment|February 12, 2021
Medicaid and Medicare Part B spending on immunomodulators and biosimilarsAlyssa M Thompson, Swetha Atluri, Kyla N Price, et al.
The Journal of Investigative Dermatology|May 29, 2020
National Institutes of Health Dermatology Funding Trends 2015-2019Kyla N Price, Erin K Collier, Swetha Atluri, et al.
The Journal of Dermatological Treatment|October 18, 2019
A practical guide for transitioning from classical immunosuppressants to dupilumab in atopic dermatitisCatherine M Ludwig, Jeffrey M Krase, Kyla N Price, et al.
Dermatology Online Journal|December 20, 2020
Widespread pustular eruption following probiotic useKyla N Price, Aleksi J Hendricks, Mackenzie E Goodrich, et al.
Dermatology (Basel, Switzerland)|December 15, 2020
Facilitating Clinical Trials Participation of Low Socioeconomic Status PatientsKyla N Price, Alexis B Lyons, Iltefat H Hamzavi, et al.
Dermatology Online Journal|April 5, 2021
Hidradenitis suppurativa patient perspectives during the COVID-19 pandemicKyla N Price, Erin K Collier, Tristan R Grogan, et al.
Endocrine Connections|August 3, 2021
Diabetes control is associated with environmental quality in the USAJyotsna S Jagai, Alison K Krajewski, Kyla N Price, et al.
Pageof 4